The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interim data: Phase I/IIa study of EGFR-targeted EDV nanocells carrying cytotoxic drug PNU-159682 (E-EDV-D682) with immunomodulatory adjuvant EDVs carrying α-galactosyl ceramide (EDV-GC) in patients with recurrent, metastatic pancreatic cancer.
 
Joanne Lundy
No Relationships to Disclose
 
Gavin M. Marx
No Relationships to Disclose
 
Jennifer MacDiarmid
Employment - EnGeneIC
Leadership - EnGeneIC
Stock and Other Ownership Interests - EnGeneIC
Research Funding - EnGeneIC
Patents, Royalties, Other Intellectual Property - EnGeneIC
 
Himanshu Brahmbhatt
Employment - EnGeneIC
Leadership - EnGeneIC
Stock and Other Ownership Interests - EnGeneIC
Research Funding - EnGeneIC
Patents, Royalties, Other Intellectual Property - EnGeneIC
 
Vinod Ganju
Honoraria - AstraZeneca; Roche/Genentech